Search results for: 'Preferred Destination for Early Phase Clinical Trials'

Sequencing technologies have evolved over the years to harness the value of the human genome and dive deep into DNA and RNA sequences which offer immense knowledge of human biology. From Sanger sequencing to next-generation sequencing, technologies and chemistries have improved/advanced to reduce costs and ensure faster timelines. NGS has integrate...

30 Mar 2023  |  North America  |  Customer Research

Global Laboratory Product Purchasing Trends, 2022–2023

End–user Perspectives on Laboratory Spending Reveals Modest 2023 Budget Increases Following robust 2022 Spending

Infographics

×

Readers of one of Frost & Sullivan’s media partners were invited to participate in an online survey from October to November 2022 examining their laboratories’ product purchasing process in 2022 and expectations for 2023. Frost & Sullivan has conducted similar studies among the same targeted respondents since 2012. The study presents year-over-...

US-based providers lose an estimated $260 billion to $270 billion annually due to poor financial risk management and lack of infrastructure to support data-driven business decisions. For every dollar claimed, private and public payers on average offer a reimbursement of 86 cents to providers, resulting in a negative margin of 14% per dollar per pat...

03 Jun 2020  |  South Asia, Middle East & North Africa  |  Market Research

Transformation Trends in Dubai’s Logistics Industry, Forecast to 2023

Effect of Disruptive Trends on Dubai’s Transport and Logistics Industry

Infographics

×

Key Issues Addressed

Since the early 2000s, Dubai has made significant economic improvement with the help of its economic diversification initiatives. Dubai’s transportation and logistics industry has also changed notably with low logistical and operational costs and favorable government policies attracting investors from around the world, marking the region as a gatew...

The medical marijuana market is growing in the United States despite the fact that the Food and Drug Administration (FDA) has not yet approved any medical marijuana products. These marijuana-based products have not yet passed through the rigorous tests and clinical trials required for medical drug approvals in the United States. At the Federal le...

31 Oct 2017  |  Global  |  Market Research

Global Digital Pathology Market, 2017 Companies-To-Action

Collaborative Business Models Embracing Artificial Intelligence Application in Novel Disease Areas to Drive Market Growth

Infographics

×

It is estimated that more than 19,000 pathologists would be needed to serve the US healthcare needs. However, the actual number is expected to be approximately 40% lesser. Similar trends are foreseen globally driven by aging population and widening application in areas such as cancer diagnostics, drug development, clinical trials, biomarker discove...

08 Feb 2018  |  North America  |  Market Research

Global Analysis of Battery Materials Market, Forecast to 2023

APAC to Remain Dominant Region Due to Key Battery OEMs Demanding Preference of Li-ion Battery Materials Suppliers in Close Proximity

Infographics

×

Key Issues Addressed

This study analyzes the global battery materials market over the period 2013-2023. There are two main types of batteries: Primary or non-rechargeable and secondary or rechargeable batteries. This research focuses on battery materials of only Li-ion and lead acid battery chemistries of the secondary type as both cover 70-80% of the total battery mat...

Pharmaceutical drug discovery and development suffers from declining success rates with new molecules, and the rate of return has shrunk from 16% in 2011 to almost 11% in 2018. Frost & Sullivan finds that traditional solutions focused primarily on data from limited sources and rule-based computational techniques used to address the understanding of...

29 Aug 2022  |  Global  |  Technology Research

Advancements in miRNA: Technology Assessment

Developments in miRNA sequencing and analysis are driving future growth potential in therapeutics and diagnostics

Infographics

×

Accelerated research around RNA-based therapeutics and diagnostics, accompanied by technology advancements in sequencing the human genome, has resulted in a better understanding of the role of miRNA in biological pathways, enhancing its potential in both therapeutics and diagnostics. The successful clinical validation of miRNA diagnostic tests has ...